Atropine Sulfate — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Atropine Sulfate. We track 57 distinct Drug Identification Numbers (DINs) for this molecule, of which 12 are currently in marketed status. Across those registrations there are 30 manufacturers or marketing authorization holders, 10 dosage forms, and 27 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Atropine Sulfate in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Atropine Sulfate product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Atropine Sulfate
Dosage forms: Solution, Drops, Ointment, Liquid, Bolus, Capsule, Elixir, Tablet (Extended-Release), Tablet, Suspension. Strengths: 1 %, 0.5 MG, 0.4 MG, 0.6 MG, 15 MG, .1 MG, 0.3 MG, 0.8 MG, .5 MG, 1 MG, 2.2 MG, 3 MG, .6 MG, 10 MG.
Manufacturers and marketing authorization holders
ALCON CANADA INC, RAFTER 8 PRODUCTS INC, PHARMA STULLN INC., NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC, PARTNAR ANIMAL HEALTH INC., HIKMA CANADA LIMITED, ALVEDA PHARMACEUTICALS INC, BIMEDA-MTC ANIMAL HEALTH INC, VETOQUINOL N A INC, ARMITAGE CARROLL, DIVISION OF LANGFORD INC., INTERNATIONAL MEDICATION SYSTEMS LTD., HOSPIRA HEALTHCARE ULC, ASTRA PHARMA INC., ORMOND VETERINARY SUPPLY LTD., PROFESSIONAL VETERINARY LABORATORIES, VETCOM 1979 INC., LABORATOIRE AGUETTANT, MTC PHARMACEUTICALS, PFIZER CANADA ULC, SANDOZ CANADA INCORPORATED, and others.
Registered products containing Atropine Sulfate
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 00035017 | ALCON ATROPINE | ALCON CANADA INC | 1 % | Solution | Marketed |
| 00238481 | ATRO-SA | RAFTER 8 PRODUCTS INC | 0.5 MG | Solution | Dormant |
| 02023695 | ATROPINE | PHARMA STULLN INC. | 1 % | Solution | Marketed |
| 01948598 | ATROPINE 1% | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | 1 % | Drops | Cancelled Post Market |
| 02376571 | ATROPINE INJECTION | PARTNAR ANIMAL HEALTH INC. | 0.5 MG | Solution | Approved |
| 02432188 | ATROPINE INJECTION BP | HIKMA CANADA LIMITED | 0.4 MG | Solution | Marketed |
| 02432196 | ATROPINE INJECTION BP | HIKMA CANADA LIMITED | 0.6 MG | Solution | Marketed |
| 02094681 | ATROPINE INJECTION BP 0.4MG/ML | ALVEDA PHARMACEUTICALS INC | 0.4 MG | Solution | Cancelled (Unreturned Annual) |
| 02094703 | ATROPINE INJECTION BP 0.6MG/ML | ALVEDA PHARMACEUTICALS INC | 0.6 MG | Solution | Cancelled (Unreturned Annual) |
| 00252484 | ATROPINE ONT 1% | ALCON CANADA INC | 1 % | Ointment | Cancelled Post Market |
| 00715492 | ATROPINE SULFATE | BIMEDA-MTC ANIMAL HEALTH INC | 0.5 MG | Solution | Dormant |
| 00516406 | ATROPINE SULFATE 1% | VETOQUINOL N A INC | 1 % | Ointment | Cancelled Post Market |
| 00331910 | ATROPINE SULFATE 15 INJ | ARMITAGE CARROLL, DIVISION OF LANGFORD INC. | 15 MG | Liquid | Cancelled Post Market |
| 00243515 | ATROPINE SULFATE INJ 0.1MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | .1 MG | Liquid | Cancelled Post Market |
| 00497223 | ATROPINE SULFATE INJ 0.3MG/ML | HOSPIRA HEALTHCARE ULC | 0.3 MG | Solution | Cancelled Post Market |
| 00243523 | ATROPINE SULFATE INJ 0.4MG/0.5ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | 0.8 MG | Solution | Cancelled Post Market |
| 00705535 | ATROPINE SULFATE INJ 0.4MG/ML | ASTRA PHARMA INC. | 0.4 MG | Solution | Cancelled Post Market |
| 00497231 | ATROPINE SULFATE INJ 0.4MG/ML | HOSPIRA HEALTHCARE ULC | 0.4 MG | Solution | Cancelled Post Market |
| 00153656 | ATROPINE SULFATE INJ 0.5MG/ML | ORMOND VETERINARY SUPPLY LTD. | .5 MG | Liquid | Cancelled Post Market |
| 00415995 | ATROPINE SULFATE INJ 0.5MG/ML | PROFESSIONAL VETERINARY LABORATORIES | .5 MG | Solution | Dormant |
| 00497258 | ATROPINE SULFATE INJ 0.6MG/ML | HOSPIRA HEALTHCARE ULC | 0.6 MG | Solution | Cancelled Post Market |
| 00705500 | ATROPINE SULFATE INJ 0.6MG/ML | ASTRA PHARMA INC. | 0.6 MG | Solution | Cancelled Post Market |
| 00416002 | ATROPINE SULFATE INJ 15MG/ML | PROFESSIONAL VETERINARY LABORATORIES | 15 MG | Solution | Dormant |
| 00497266 | ATROPINE SULFATE INJ 1MG/ML | HOSPIRA HEALTHCARE ULC | 1 MG | Solution | Cancelled Post Market |
| 00501360 | ATROPINE SULFATE INJ 2.2MG/ML | VETCOM 1979 INC. | 2.2 MG | Liquid | Cancelled Post Market |
| 02426285 | ATROPINE SULFATE INJECTION | LABORATOIRE AGUETTANT | 3 MG | Solution | Approved |
| 02426269 | ATROPINE SULFATE INJECTION | LABORATOIRE AGUETTANT | 0.5 MG | Solution | Marketed |
| 02426277 | ATROPINE SULFATE INJECTION | LABORATOIRE AGUETTANT | 1 MG | Solution | Marketed |
| 00720917 | ATROPINE SULFATE INJECTION 2.2MG/ML | MTC PHARMACEUTICALS | 2.2 MG | Liquid | Cancelled Post Market |
| 02472171 | ATROPINE SULFATE INJECTION USP | PFIZER CANADA ULC | 0.5 MG | Solution | Cancelled Post Market |
| 00392782 | ATROPINE SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | 0.4 MG | Solution | Marketed |
| 00328154 | ATROPINE SULFATE INJECTION USP | PFIZER CANADA ULC | 1 MG | Solution | Cancelled Post Market |
| 00392693 | ATROPINE SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | .6 MG | Solution | Marketed |
| 02212951 | ATROPINE SULPHATE 1% - LIQ OPH | RIVEX OPHTHALMICS INC. | 1 % | Liquid | Cancelled Post Market |
| 02134853 | ATROPISOL | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | 10 MG | Drops | Cancelled Post Market |
| 00759929 | ATROPISOL OPH SOLN 1% | IOLAB PHARMACEUTICALS | 1 % | Drops | Cancelled Post Market |
| 00308390 | CALF SCOUR BOLUS | PROFESSIONAL VETERINARY LABORATORIES | 350 MG | Bolus | Marketed |
| 02041626 | DIBAN CAP | WYETH-AYERST CANADA INC. | 3.3 MCG | Capsule | Cancelled Post Market |
| 01909215 | DIBAN CAP | AYERST LABORATORIES | 300 MG | Capsule | Cancelled Post Market |
| 01908006 | DONNAGEL LIQ | AYERST LABORATORIES | 6 G | Liquid | Cancelled Post Market |
| 02041774 | DONNAGEL LIQ | WYETH-AYERST CANADA INC. | 6 G | Liquid | Cancelled Post Market |
| 01909282 | DONNATAL ELIXIR | AYERST LABORATORIES | 16.2 MG | Elixir | Cancelled Post Market |
| 02042894 | DONNATAL ELIXIR | WYETH-AYERST CANADA INC. | 16.2 MG | Elixir | Cancelled Post Market |
| 01909274 | DONNATAL EXTENTABS | AYERST LABORATORIES | 48.6 MG | Tablet (Extended-Release) | Cancelled Post Market |
| 02042908 | DONNATAL EXTENTABS SRT | WYETH-AYERST CANADA INC. | 48.6 MG | Tablet (Extended-Release) | Cancelled Post Market |
| 02042916 | DONNATAL TAB | WYETH-AYERST CANADA INC. | 16.2 MG | Tablet | Cancelled Post Market |
| 02098660 | ERVOPAX TAB | HOMEOCAN INC. | 3 D | Tablet | Cancelled Post Market |
| 00308242 | HOG SCOUR SUSPENSION | PROFESSIONAL VETERINARY LABORATORIES | 20 MG | Suspension | Dormant |
| 00036323 | LOMOTIL | PFIZER CANADA ULC | 2.5 MG | Tablet | Marketed |
| 02148358 | MINIMS ATROPINE SULPHATE | BAUSCH & LOMB INC | 1 % | Drops | Marketed |
| 00622907 | ODAN-ATROPINE | ODAN LABORATORIESLTD | 1 % | Drops | Dormant |
| 01901311 | R.O.-ATROPINE | RICHMOND PHARMACEUTICALS INC. | 1 % | Liquid | Cancelled Post Market |
| 00566691 | RENAZONE PLUS TAB | ORMOND VETERINARY SUPPLY LTD. | 100 MG | Tablet | Cancelled Post Market |
| 00260045 | SCOUR BOLUSES | DOMINION VETERINARY LABORATORIES LTD. | 400 MG | Bolus | Dormant |
| 00274895 | SCOUR SUSPENSION | DOMINION VETERINARY LABORATORIES LTD. | 28.6 MG | Suspension | Marketed |
| 02026384 | SPASCUPREEL INJEEL LIQ | BIOLOGISCHE HEILMITTEL HEEL GMBH | 4 D | Liquid | Cancelled Post Market |
| 02029723 | SPASCUPREEL TABLETS | BIOLOGISCHE HEILMITTEL HEEL GMBH | 4 D | Tablet | Cancelled Post Market |
Sourcing Atropine Sulfate through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Atropine Sulfate we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Atropine Sulfate and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.